Lv2
130 积分 2021-02-28 加入
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
6小时前
已完结
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
1个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
1个月前
已完结
Towards precision medicine in COPD: Targeting type 2 cytokines and alarmins
1个月前
已完结
Successful Osimertinib Rechallenge After Relapse Following Adjuvant Osimertinib: A Case Report
7个月前
已完结
Histopathological Evidence for a Non-Inflammatory Mechanism in Osimertinib-Induced Myopathy: A Case Report
7个月前
已完结
Clinical and translational attributes of immune-related adverse events
1年前
已完结
Pulmonary embolism
1年前
已完结
The cGAS–STING pathway and cancer
2年前
已完结
Pulmonary Nodules, Lung Cancer Screening and Lung Cancer in the Medicare Population
2年前
已完结
皖公网安备34019202002308
